Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
How China turned the 'Sea of Death' into a solar oasis 2024-09-26 22:00
A remarkable journey: from 'poor and blank' to a rich and powerful China 2024-09-26 13:26
Henan courts global investors to propel economic growth 2024-09-26 09:44
Xinhua Silk Road: Cultural event held in SE. China's Dehua to foster cultural exchange, boost global cooperation in ceramic industry 2024-09-26 08:59
Why is China attractive for international investors to set up tech businesses? 2024-09-25 21:00
"Princess Adachi Festival: A Celebration of Wishes" - December 18-19, 2024, in Kita-Senju! 2024-09-25 18:55
GCI is China's solution to promote progress of human civilization 2024-09-25 12:12
Global Times: 75 years of evolution: China's consumption evolves and unfolds unlimited potential 2024-09-25 08:30
Paws and Profits: How can foreign enterprises tap into China's booming pet economy? 2024-09-24 21:00
Bilingual Animation: The Wisdom of Confucius - On Behavior 2024-09-24 17:28
China has proven it can do very unexpected and surprising things 2024-09-24 16:26
Global Times: Generation Z connect China and the world digitally: report 2024-09-24 15:02
Global Times: Xi calls for accelerating progress in space endeavors amid fruitful results of lunar exploration 2024-09-24 09:39
Global Times: World needs dialogue, co-op instead of tension, confrontation: scholars, experts at Beijing forum 2024-09-23 16:51
Silk Road expo explores international cultural exchanges 2024-09-23 13:57
State Grid Yiyuan County Power Supply Company: Free Door-to-door "Diagnosis" for the Healthy Development of the Cold Storage Industry 2024-09-20 14:00
Beijing, Where Events Come Alive! Sports Services Section of CIFTIS 2024 Opened 2024-09-18 05:38
Cooperation zone's successes celebrated in anniversary publication 2024-09-17 10:00
Harvard Business School examines DBS' AI strategy and implementation in its first case study focusing on AI in an Asian bank 2024-09-16 22:00
Akeso Published Ivonescimab plus Ligufalimab as First-Line Treatment for PD-L1-Positive Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma at ESMO 2024 2024-09-15 15:10
1 8 9 10 11 12 304